QUIDELORTHO CORP Gain (Loss) on Extinguishment of Debt
QUIDELORTHO CORP (QDEL) reported Gain (Loss) on Extinguishment of Debt of -$5.10 million for the 12-month period ending 2025-12-28, per its 10-K filed 2026-02-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-02-19
- QUIDELORTHO CORP gain (loss) on extinguishment of debt for the quarter ending 2025-12-28 was $0.00.
- QUIDELORTHO CORP gain (loss) on extinguishment of debt for the quarter ending 2025-09-28 was -$5.10M.
- QUIDELORTHO CORP gain (loss) on extinguishment of debt for the quarter ending 2024-12-29 was $0.00.
- QUIDELORTHO CORP gain (loss) on extinguishment of debt for the quarter ending 2024-09-29 was $0.00.
- QUIDELORTHO CORP gain (loss) on extinguishment of debt for fiscal 2025 was -$5.10M.
- QUIDELORTHO CORP gain (loss) on extinguishment of debt for fiscal 2024 was $0.00.
- QUIDELORTHO CORP gain (loss) on extinguishment of debt for fiscal 2023 was $0.00.
- QUIDELORTHO CORP gain (loss) on extinguishment of debt for fiscal 2023 was -$24.00M.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2025-12-28 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$5.10M derived: sum of 2 quarters · filed 2026-02-19 | -$5.10M 10-K · filed 2026-02-19 | |
| 2025-09-28 | -$5.10M 10-Q · filed 2025-11-06 | -$5.10M 10-Q · filed 2025-11-06 | ||
| 2024-12-29 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $0.00 derived: sum of 2 quarters · filed 2026-02-19 | $0.00 10-K · filed 2026-02-19 | |
| 2024-09-29 | $0.00 10-Q · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $0.00 derived: sum of 2 quarters · filed 2026-02-19 | $0.00 derived: sum of 3 quarters · filed 2026-02-19 | $0.00 10-K · filed 2026-02-19 |
| 2023-10-01 | $0.00 10-Q · filed 2023-11-02 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 | |
| 2023-07-02 | $0.00 10-Q · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | ||
| 2023-01-01 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | -$24.00M derived: sum of 3 quarters · filed 2025-02-27 | -$24.00M 10-K · filed 2025-02-27 |
| 2022-10-02 | $0.00 10-Q · filed 2023-11-02 | -$24.00M derived: sum of 2 quarters · filed 2023-11-02 | -$24.00M 10-Q · filed 2023-11-02 | |
| 2022-07-03 | -$24.00M 10-Q · filed 2023-08-09 | -$24.00M 10-Q · filed 2023-08-09 | ||
| 2022-01-02 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-01 | $0.00 derived: sum of 2 quarters · filed 2024-08-01 | $0.00 derived: sum of 3 quarters · filed 2024-08-01 | $0.00 10-K/A · filed 2024-08-01 |
| 2021-10-03 | $0.00 10-Q · filed 2022-11-04 | $0.00 derived: sum of 2 quarters · filed 2022-11-04 | $0.00 10-Q · filed 2022-11-04 | |
| 2021-07-04 | $0.00 10-Q · filed 2022-08-05 | $0.00 10-Q · filed 2022-08-05 | ||
| 2021-01-03 | -$10.40M 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |